Yang Han, Tan Huiwen, Huang He, Li Jianwei
Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
Department of Endocrinology and Metabolism, Chongqing Sixth People's Hospital, Chongqing, China.
Front Oncol. 2021 Apr 2;11:640999. doi: 10.3389/fonc.2021.640999. eCollection 2021.
Cardiovascular-related complications are one of the most common complications in patients with acromegaly, and can lead to an increased risk of death. Hypertension and cardiomyopathy are the main cardiovascular complications. The characteristics of acromegalic cardiomyopathy are concentric biventricular hypertrophy and diastolic dysfunction. In addition, arrhythmia and heart valve disease are common cardiac complications in acromegaly. Although the underlying pathophysiology has not been fully elucidated, the spontaneous overproduction of GH and IGF-1, increasing age, prolonged duration of disease and the coexistence of other cardiovascular risk factors are crucial to cardiac complications in patients with acromegaly. Early diagnosis and appropriate treatment of acromegaly might be beneficial for the prevention of cardiomyopathy and premature death.
心血管相关并发症是肢端肥大症患者最常见的并发症之一,可导致死亡风险增加。高血压和心肌病是主要的心血管并发症。肢端肥大症性心肌病的特征是双心室向心性肥厚和舒张功能障碍。此外,心律失常和心脏瓣膜病是肢端肥大症常见的心脏并发症。虽然潜在的病理生理学尚未完全阐明,但生长激素(GH)和胰岛素样生长因子-1(IGF-1)的自发过度分泌、年龄增长、疾病持续时间延长以及其他心血管危险因素的共存,对于肢端肥大症患者的心脏并发症至关重要。早期诊断和适当治疗肢端肥大症可能有助于预防心肌病和过早死亡。